ASP Newsletter

Inaugural ASP Vanguards Virtual Symposium Series a Great Success!

October 11, 2021 by ASP Newsletter

By C. Benjamin Naman, PhD and Karen VanderMolen, PhD As we collectively surpass a year and a half together in the global COVID-19 pandemic, many of us suffer from online meeting fatigue and sore monitor eyes. The ASP overcame these…

ASP President McPhail Addresses Members

October 8, 2021 by ASP Newsletter

Dr. Kerry McPhail PHOTO: DANIEL SEEMILLER By Kerry McPhail, PhD NOTE: A video of President McPhail’s address to members at the July 28th ASP Business Meeting is available at www.pharmacognosy.us/presidential-remarks-asp-business-meeting-2021/ I am profoundly moved and honored to have this opportunity…

Fieldwork with Family… and a Fake Leg

August 25, 2021 by ASP Newsletter

Cassandra L. Quave, Ph.D. My husband, Marco, and I welcomed our first of three children in the fall of 2005. I was a graduate student at Florida International University in Miami, FL at the time, and finished my qualifying exams…

Working in Cannabis

August 11, 2021 by ASP Newsletter

By Daniel Kulakowski, PhD Dr. Daniel Kulakowski in his analytical laboratory at Steep Hill, Maryland If you would like to work with one of the most widely used plant medicines in the country and enjoy the opportunity to directly impact…

HOT TOPICS IN PHARMACOGNOSY: So What About the Other Half of Kinase Inhibitor Activities?

July 12, 2021 by ASP Newsletter

By David J. Newman, DPhil INTRODUCTION Although we have been inundated over the years with stories of the successes with inhibiting protein tyrosine kinases (aka PTKs) and their chemical cousins, based on other amino acids such as serine or threonine…